ICD-10-CM code · FY2027
E16.2 Hypoglycemia, unspecified
BillableValid for claims as a specific diagnosis code
About E16.2
- Code
- E16.2
- Billable
- Yes
- Short description
- Hypoglycemia, unspecified
- Category
- E16 Other disorders of pancreatic internal secretion
- Block
- E15-E16 Other disorders of glucose regulation and pancreatic internal secretion
- Chapter
- 4 Endocrine, nutritional and metabolic diseases
- Code set
- FY2027, October 1, 2026 to September 30, 2027
EvidencePulse™by 2 Minute Medicine®
Go deeper into hypoglycemia.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for E16.2
Excludes1 Not coded here: never report these together with this code (use the code given instead).
Use additional code Add a second code for the detail named here.
- code for hypoglycemia level, if applicable (E16.A-)
Chapter 4 notes (apply to every code in it)
Note
- All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Related codes in E16
- E16.0 Drug-induced hypoglycemia without comaBillable
- E16.1 Other hypoglycemiaBillable
- E16.3 Increased secretion of glucagonBillable
- E16.4 Increased secretion of gastrinBillable
- E16.8 Other specified disorders of pancreatic internal secretionBillable
- E16.9 Disorder of pancreatic internal secretion, unspecifiedBillable
- E16.A Hypoglycemia levelHeader
Latest research on hypoglycemia
- Metformin is associated with lowering maternal hyperglycemia and reducing the risk of neonatal hypoglycemia among pregnant patients at risk of preterm delivery
- Machine learning model non-invasively detects suspected cases of hypoglycemia during real-world driving
- Neonatal hypoglycemia not significantly associated with lower educational achievement during childhood
- Treatment at lower glucose threshold noninferior to traditional threshold in newborns with asymptomatic hypoglycemia
- In topline phase 3 results, retatrutide lowered A1C more and reduced weight more than semaglutide 2 mg at 80 weeks
Landmark trials from 2MM Classics
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app